This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: The University of Texas System, University of California. Active years: 1996.
Company Filing History:
1 out of 5,630 
1 out of 15,988 
Years Active: 1996
Title: Peter J Sheridan: Innovator in Compulsive Disorder Diagnosis
Introduction
Peter J Sheridan is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of genetics and mental health through his innovative patent. His work focuses on diagnosing susceptibility to compulsive disorders, which has important implications for treatment and prevention.
Latest Patents
Peter J Sheridan holds a patent for "Allelic diagnosis of susceptibility to compulsive disorder." This invention involves a method for diagnosing and detecting an individual's susceptibility to compulsive disorders. The process begins with obtaining a DNA sample from the individual and determining the presence or absence of specific human D₂ receptor gene alleles. The detection of these alleles indicates a predisposition to various compulsive disorders, including alcoholism, obesity, smoking, and drug addiction. The most preferred alleles to be detected in the sample are the human D₂ receptor gene A1, B1, and In6-Ex7 haplotype I alleles.
Career Highlights
Throughout his career, Peter J Sheridan has worked with prestigious institutions, including the University of Texas System and the University of California. His research has contributed to a better understanding of the genetic factors associated with compulsive behaviors.
Collaborations
Peter has collaborated with notable individuals in his field, including Kenneth J Blum and Ernest P Noble. Their combined expertise has further advanced the research on compulsive disorders and their genetic underpinnings.
Conclusion
Peter J Sheridan's innovative work in the diagnosis of compulsive disorders highlights the intersection of genetics and mental health. His contributions are paving the way for improved diagnostic methods and potential treatments for individuals affected by these conditions.